Defilade Capital Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002088557

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2026 Q1 2026 Q4 2025

Q2 2026 · 39 positions · Total reported value $746.95M · Top-10 concentration 46.5% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 80.0% · 19 new · 10 cut · 11 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +7.9% · vs SPY -6.9% · Prev Value $712.18M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Defilade Capital Management, L.P. disclosed 39 equity positions with a combined reported value of $746.95M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.5% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were LLY ($46.88M), PFE ($42.66M), VEEV ($42.01M). By sector, the heaviest allocations are Health Care 89.7%, Technology 5.6%. Versus the prior quarter, allocation shifted toward Technology (+5.6pp), Industrials (+3.5pp) and away from Other (-0.7pp), Health Care (-8.4pp).

Versus the prior quarter, Defilade Capital Management, L.P. opened 19 new positions, trimmed 10 and fully exited 11, a turnover rate of 80.0% of positions. The portfolio's overlap with the prior quarter was 40% of names.

The largest new positions opened in Q2 2026 were VEEV ($42.01M), BMRN ($39.02M), BAX ($31.11M).

Of the 11 positions fully exited versus the prior quarter, the largest were HSIC ($45.99M), BDX ($43.90M), DXCM ($33.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • VEEV VEEVA SYS INC · $42.01M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $39.02M
  • BAX BAXTER INTL INC COM · $31.11M
  • PODD INSULET CORP · $26.94M
  • TMO THERMO FISHER · $26.04M
  • ABT ABBOTT LABORATORIES · $25.93M
  • SOLV SOLVENTUM CORP COM SHS · $24.41M
  • MDT MEDTRONIC PLC · $23.73M

Fully Exited (vs previous quarter)

  • HSIC HENRY SCHEIN INC · prev qtr: $45.99M
  • BDX BECTON DICKINSON & CO COM · prev qtr: $43.90M
  • DXCM DEXCOM INC COM · prev qtr: $33.83M
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $31.20M
  • NBIX NEUROCRINE BIOSCIENCES I · prev qtr: $27.66M
  • ITGR INTEGER HOLDINGS CORP · prev qtr: $18.75M
  • BIIB BIOGEN INC COM · prev qtr: $17.65M
  • TNDM TANDEM DIABETES CARE INC · prev qtr: $14.61M

Insider Transactions (Form 4)

Latest Defilade Capital Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Defilade Capital Management, L.P. is an SEC-registered 13F filer based in Emeryville, CA, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $746.95M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Firm Snapshot

  • Headquarters: EMERYVILLE, CA, United States
  • SEC registration: 801-134248 (status: Approved), registered 2025-08-27
  • Regulatory AUM (Form ADV): $1.55B as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: defcap.com

Portfolio Structure

  • 39 positions · $746.95M reported value (Q2 2026)
  • Top 10 holdings = 46.5% of reported value
  • Largest position: LLY (ELI LILLY & CO) at 6.3%
  • Average position size: $19.15M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 5.6%
  • Industrials 3.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 19 new, 8 added, 10 reduced, 11 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 89.7%
Technology 5.6%
Other 1.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 39.09K $46.88M 6.28%
6.28%
Add
2 1.77M $42.66M 5.71%
5.71%
Add
3 236.71K $42.01M 5.62%
5.62%
New
4 682.00K $39.02M 5.22%
5.22%
New
5 433.70K $35.38M 4.74%
4.74%
Add
6 1.46M $31.11M 4.17%
4.17%
New
7 281.84K $30.05M 4.02%
4.02%
Add
8 317.43K $27.33M 3.66%
3.66%
Reduce
9 176.93K $26.94M 3.61%
3.61%
New
10 51.93K $26.04M 3.49%
3.49%
New
11 285.78K $25.93M 3.47%
3.47%
New
12 94.84K $25.30M 3.39%
3.39%
Add
13 316.45K $24.41M 3.27%
3.27%
New
14 303.30K $23.73M 3.18%
3.18%
New
15 864.08K $21.27M 2.85%
2.85%
Reduce
16 546.85K $20.29M 2.72%
2.72%
New
17 726.11K $19.13M 2.56%
2.56%
New
18 82.83K $15.51M 2.08%
2.08%
Reduce
19 105.70K $15.50M 2.08%
2.08%
Reduce
20 393.44K $15.23M 2.04%
2.04%
Add
21 132.66K $14.72M 1.97%
1.97%
Reduce
22 1.49M $14.63M 1.96%
1.96%
Hold
23 3.53M $13.89M 1.86%
1.86%
Reduce
24 376.87K $12.04M 1.61%
1.61%
New
25 924.76K $11.57M 1.55%
1.55%
Reduce
26 1.05M $11.35M 1.52%
1.52%
Add
27 3.67M $11.19M 1.50%
1.50%
New
28 139.64K $11.03M 1.48%
1.48%
Reduce
29 531.95K $11.01M 1.47%
1.47%
New
30 793.14K $10.54M 1.41%
1.41%
Add
31 80.12K $10.16M 1.36%
1.36%
New
32 391.87K $10.08M 1.35%
1.35%
Reduce
33 66.52K $9.30M 1.25%
1.25%
New
34 322.13K $9.24M 1.24%
1.24%
New
35 215.68K $9.20M 1.23%
1.23%
Reduce
36 239.44K $8.96M 1.20%
1.20%
New
37 107.37K $8.83M 1.18%
1.18%
New
38 1.67M $3.10M 0.41%
0.41%
New
39 7.56M $2.40M 0.32%
0.32%
Hold

FAQ

What did Defilade Capital Management, L.P. buy in 2026-Q2?

In its 2026-Q2 13F filing, Defilade Capital Management, L.P. reported 39 equity positions worth $746.95M in aggregate; its largest disclosed positions were LLY ($46.88M), PFE ($42.66M), VEEV ($42.01M).

How large is Defilade Capital Management, L.P.'s portfolio?

Defilade Capital Management, L.P. reported $746.95M of long equity holdings across 39 positions as of 2026-Q2. Top-10 holdings account for 46.5% of reported value.

What is Defilade Capital Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/defilade-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →